NCT03306082

Brief Summary

Cochlear implants are surgically implanted devices which restore the ability to hear to the hearing impaired. While remarkably successful, even in the best of performers restoration of hearing to levels of normal listeners is unusual. Approximately 3 weeks after surgery, cochlear implants are activated via mapping - a process in which each individual electrode (FDA approved cochlear implants have between 12 and 22 electrodes) is turned on and the stimulus level adjusted to a level that is comfortable and beneficial to the recipient. At present, this standard of care mapping procedure is performed without knowledge of the physical location between the cochlear implant electrodes and the neural interface. The research team has developed a new method of mapping using post-operative CT scans and image processing to specify the physical relationship between the cochlear implant electrodes and the neural interface allowing customized mapping. Using this information, the investigators deactivate sub-optimally positioned electrodes. The investigators term this "Image-guided Cochlear Implant Programming" (IGCIP). The study collects data in a prospective fashion for those CI recipient undergoing IGCIP.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
13mo left

Started Jun 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Jun 2015May 2027

Study Start

First participant enrolled

June 23, 2015

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

October 4, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 10, 2017

Completed
8.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2027

Last Updated

July 17, 2025

Status Verified

July 1, 2025

Enrollment Period

10.9 years

First QC Date

October 4, 2017

Last Update Submit

July 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • AzBio Sentence Scores at +5 Signal to Noise Ratio (SNR)

    Month 1 post cochlear implant activation

Secondary Outcomes (1)

  • Minimum Speech Test Battery

    Month 1 post cochlear implant activation

Study Arms (1)

Image-guided Cochlear Implant Programming (IGCIP)

EXPERIMENTAL

Cochlear implant programming using IGCIP.

Other: Image-Guided Cochlear Implant Programming

Interventions

Post Cochlear Implant surgery, participant will receive traditional activation and programming per routine. IGCIP will be used to offer alternative programming of the implant.

Image-guided Cochlear Implant Programming (IGCIP)

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 to 90 years that have undergone diagnostic testing for sensorineural hearing loss and have received a cochlear implant with asymptotic improvement in performance with SOC programming will be considered eligible for the study.

You may not qualify if:

  • Age \< 18 years or \> 90 years
  • Non-English speaking (because our audiological speech testing battery is validated for English speakers)
  • Pregnancy which is a contraindication for elective CT scanning and surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

Location

Study Officials

  • Jack H. Noble, PhD

    Vanderbilt University

    PRINCIPAL INVESTIGATOR
  • Rene H. Gifford, PhD

    Vanderbilt University Medical Center

    STUDY CHAIR
  • Robert F. Labadie, MD, PhD

    Vanderbilt University Medical Center

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Prospective Cohort study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor, Electrical Engineering and Computer Science

Study Record Dates

First Submitted

October 4, 2017

First Posted

October 10, 2017

Study Start

June 23, 2015

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

May 31, 2027

Last Updated

July 17, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations